Shares of Dr. Martens plc (LON:DOCS - Get Free Report) shot up 24.7% on Thursday . The company traded as high as GBX 75.30 ($1.02) and last traded at GBX 74.75 ($1.01). 8,151,296 shares were traded during trading, an increase of 262% from the average session volume of 2,251,775 shares. The stock had previously closed at GBX 59.95 ($0.81).
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($94.70) to GBX 6,000 ($81.17) and set a "sector perform" rating for the company in a report on Monday, May 19th.
Check Out Our Latest Analysis on Dr. Martens
Dr. Martens Stock Up 8.7%
The firm's 50 day simple moving average is GBX 54.73 and its 200-day simple moving average is GBX 62.64. The company has a market cap of £795.54 million, a price-to-earnings ratio of 11.62, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens (LON:DOCS - Get Free Report) last announced its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, sell-side analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Dr. Martens Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were issued a GBX 0.85 ($0.01) dividend. This represents a dividend yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's payout ratio is currently 42.53%.
Insider Transactions at Dr. Martens
In other Dr. Martens news, insider Giles Wilson bought 32,640 shares of the firm's stock in a transaction dated Tuesday, March 25th. The stock was acquired at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,844.16). Over the last ninety days, insiders have acquired 33,206 shares of company stock worth $1,792,771. Insiders own 4.36% of the company's stock.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
See Also
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
